CIK: 0001777015
Total reported value
$969.6M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 5.01% | — | — | |
| 2 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.42% | -1.64% | +53.40% | |
| 3 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 4.17% | -0.89% | -5.03% | |
| 4 | PODD | Insulet CORP | Stock-Healthcare | 3.74% | -0.42% | +9.91% | |
| 5 | CVS | Cvs Health CORP | Stock-Healthcare | 2.98% | -0.53% | -26.71% | |
| 6 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 2.72% | -1.32% | +37.40% | |
| 7 | VRDN | Viridian Therapeutics INC | Stock-Other | 2.60% | -1.20% | -11.11% | |
| 8 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 2.58% | +1.22% | +4.59% | |
| 9 | SYK | Stryker CORP | Stock-Healthcare | 2.47% | +1.71% | +27.26% | |
| 10 | QGEN | Qiagen N.V. | Stock-Healthcare | 2.33% | -2.12% | EXIT | |
| 11 | MCK | Mckesson CORP | Stock-Healthcare | 2.30% | -1.71% | +63.49% | |
| 12 | DHR | Danaher CORP | Stock-Healthcare | 2.29% | -1.28% | EXIT | |
| 13 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 2.20% | +1.09% | +155.50% | |
| 14 | QURE | uniQure N.V. | Stock-Other | 2.10% | — | -22.12% | |
| 15 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 2.08% | — | -14.57% | |
| 16 | BIIB | Biogen INC | Stock-Healthcare | 1.90% | -0.59% | EXIT | |
| 17 | MLYS | Mineralys Therapeutics INC | Stock-Other | 1.80% | -0.36% | -1.74% | |
| 18 | UPB | Upstream Bio INC | Stock-Other | 1.65% | -1.43% | +17.89% | |
| 19 | THC | Tenet Healthcare CORP | Stock-Healthcare | 1.57% | — | -55.99% | |
| 20 | XERS | Xeris Biopharma Holdings INC | Stock-Other | 1.52% | — | -14.99% | |
| 21 | LIVN | LivaNova PLC | Stock-Other | 1.51% | — | +57.61% | |
| 22 | MBX | Mbx Biosciences INC | Stock-Other | 1.41% | — | -11.31% | |
| 23 | AM6 | Amicus Therapeutics INC | Stock-Other | 1.39% | -2.02% | EXIT | |
| 24 | DOCS | Doximity Inc-class A | Stock-Healthcare | 1.37% | -0.68% | EXIT | |
| 25 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 1.36% | +1.02% | -2.41% | |
| 26 | PTCT | Ptc Therapeutics INC | Stock-Healthcare | 1.30% | +1.87% | +11.41% | |
| 27 | ACLXGBX | Arcellx INC | Stock-Other | 1.28% | -0.80% | EXIT | |
| 28 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.26% | — | -38.12% | |
| 29 | COO | Cooper Cos Inc/the | Stock-Healthcare | 1.26% | — | -54.21% | |
| 30 | WAY | Waystar Holding CORP | Stock-Other | 1.21% | — | +118.59% | |
| 31 | DXCM | Dexcom INC | Stock-Healthcare | 1.20% | — | -24.02% | |
| 32 | CSTL | Castle Biosciences INC | Stock-Other | 1.13% | — | +35.00% | |
| 33 | OPRX | Optimizerx CORP | Stock-Other | 1.09% | — | +0.43% | |
| 34 | NUVL | Nuvalent Inc-a | Stock-Other | 1.08% | — | +0.47% | |
| 35 | ATEC | Alphatec Holdings INC | Stock-Other | 1.06% | — | +7.41% | |
| 36 | AORT | Artivion INC | Stock-Other | 0.98% | — | +14.71% | |
| 37 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.96% | — | +149.69% | |
| 38 | AXGN | Axogen INC | Stock-Other | 0.93% | — | -25.61% | |
| 39 | EWTX | Edgewise Therapeutics INC | Stock-Other | 0.93% | — | -15.01% | |
| 40 | RCUS | Arcus Biosciences INC | Stock-Other | 0.93% | — | +8.85% | |
| 41 | INCY | Incyte CORP | Stock-Healthcare | 0.89% | — | +33.92% | |
| 42 | TVTX | Travere Therapeutics INC | Stock-Other | 0.85% | — | -58.92% | |
| 43 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.84% | — | +127.84% | |
| 44 | ASND | Ascendis Pharma A/S | Stock-Other | 0.84% | — | -4.19% | |
| 45 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 0.82% | — | -10.90% | |
| 46 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 0.80% | +1.01% | +0.46% | |
| 47 | VCYT | Veracyte INC | Stock-Other | 0.80% | — | +1.22% | |
| 48 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.80% | +3.28% | NEW | |
| 49 | QDEL | Quidelortho CORP | Stock-Other | 0.78% | — | -34.61% | |
| 50 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.74% | +2.32% | +17.13% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals INC | +2% | -5.03% | Add |
| 2 | QURE | uniQure N.V. | +1.8% | -22.12% | Add |
| 3 | BSX | Boston Scientific CORP | +1.7% | +53.40% | Add |
| 4 | UPB | Upstream Bio INC | +1.5% | +17.89% | Add |
| 5 | MLYS | Mineralys Therapeutics INC | +1.3% | -1.74% | Add |
| 6 | 4XC1 | Kalvista Pharmaceuticals INC | +1.2% | +155.50% | Add |
| 7 | MBX | Mbx Biosciences INC | +1.1% | -11.31% | Add |
| 8 | VRDN | Viridian Therapeutics INC | +0.9% | -11.11% | Add |
| 9 | AM6 | Amicus Therapeutics INC | +0.8% | +177.23% | Add |
| 10 | ACLXGBX | Arcellx INC | +0.8% | -14.02% | Add |
| 11 | DHR | Danaher CORP | +0.8% | +0.41% | Add |
| 12 | LIVN | LivaNova PLC | +0.7% | +57.61% | Add |
| 13 | DOCS | Doximity Inc-class A | +0.7% | +48.11% | Add |
| 14 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.7% | +37.40% | Trim |
| 15 | AORT | Artivion INC | +0.7% | +14.71% | Add |
| 16 | QGEN | Qiagen N.V. | +0.6% | +0.41% | Add |
| 17 | OPRX | Optimizerx CORP | +0.6% | +0.43% | Add |
| 18 | UTHR | United Therapeutics CORP | +0.6% | +149.69% | Add |
| 19 | MCK | Mckesson CORP | +0.5% | +63.49% | Add |
| 20 | ATEC | Alphatec Holdings INC | +0.5% | +7.41% | Add |
| 21 | SNDX | Syndax Pharmaceuticals INC | +0.5% | -2.41% | Add |
| 22 | DAWNGBX | Day One Biopharmaceuticals I | -0.8% | -39.65% | Trim |
| 23 | SYK | Stryker CORP | -1% | +27.26% | Trim |
| 24 | RARE | Ultragenyx Pharmaceutical In | -1.1% | -53.62% | Trim |
| 25 | MNKD | Mannkind CORP | -1.1% | -65.49% | Trim |
| 26 | TVTX | Travere Therapeutics INC | -1.2% | -58.92% | Trim |
| 27 | CVRX | Cvrx INC | -1.4% | -37.73% | Trim |
| 28 | RXST | Rxsight INC | -1.5% | -39.94% | Trim |
| 29 | BMRN | Biomarin Pharmaceutical INC | -1.6% | -44.06% | Trim |
| 30 | THC | Tenet Healthcare CORP | -1.8% | -55.99% | Trim |
| 31 | COO | Cooper Cos Inc/the | -1.9% | -54.21% | Trim |
| 32 | LLY | Eli Lilly & Co | -3% | -69.97% | Trim |
| 33 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 34 | BDX | Becton Dickinson And Co | — | EXIT | Sold out |
| 35 | UNH | Unitedhealth Group INC | — | EXIT | Sold out |
| 36 | GILD | Gilead Sciences INC | — | EXIT | Sold out |
| 37 | BIIB | Biogen INC | — | NEW | New buy |
| 38 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |
| 39 | RVTY | Revvity INC | — | EXIT | Sold out |
| 40 | WAY | Waystar Holding CORP | — | NEW | New buy |
| 41 | DGX | Quest Diagnostics INC | — | EXIT | Sold out |
| 42 | REPL | Replimune Group INC | — | EXIT | Sold out |
| 43 | INCY | Incyte CORP | — | NEW | New buy |
| 44 | ASND | Ascendis Pharma A/S | — | NEW | New buy |
| 45 | AMLX | Amylyx Pharmaceuticals INC | — | NEW | New buy |
| 46 | ANIP | Ani Pharmaceuticals INC | — | EXIT | Sold out |
| 47 | CERT | Certara INC | — | NEW | New buy |
| 48 | ASMB | Assembly Biosciences INC | — | NEW | New buy |
| 49 | STOK | Stoke Therapeutics INC | — | NEW | New buy |
| 50 | IQV | Iqvia Holdings INC | — | NEW | New buy |